Skip to main content

SBC Medical Group Holdings Inc

corporate_fare Company Profile

SBC Medical Group Holdings Inc

SBC·NASDAQ·Industrial Applications And Services·CIK 0001930313

SBC Medical Group Holdings Incorporated provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and Singapore. The company offers a range of services including advertising and marketing across social media, staff recruitment and training, and booking reservations for franchisee clinic customers. It also assists with franchisee employee housing rentals, leasehold improvements, and design services for clinics, medical equipment, and medical consumables procurement. SBC Medical Group Holdings provides loyalty program management, labor and function support, management consulting, and IT software solutions. The company engages in franchising activities and distributes medical equipment, devices, implants, injection materials, other medical consumables, skin care and beauty products, and cosmetic products to franchisee clinics for resale. Its services encompass surgical and non-surgical cosmetic treatments such as breast augmentation, liposuction, rejuvenation treatments for wrinkles, acne, scars, cellulite, excess fat, discoloration, and aging signs, laser skin toning and spot removal, eyes double fold surgery, rhinoplasty, treatment of osmidrosis and hyperhidrosis, hair transplants, gynecological formation treatments, laser hair removal, face line surgeries, cosmetical dental procedures, tattoo removal, LASIK eye surgery, lateral canthoplasty, brow lift procedures, androgenetic alopecia treatment, and cheek sagging prevention methods. Additionally, SBC Medical Group Holdings owns and operates treatment centers under the SBC brand. The company was founded in 2000 and is headquartered in Irvine, California.

SBC Medical Group Holdings Inc (NASDAQ:SBC) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 25 items for SBC at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-19, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 16 rated 8 or above. Recent SEC coverage for SBC spans 8-K, 10-Q, DEF 14A, PRE 14A.

Recent high-impact activity:

  • SBC Medical Discloses Breach of 1.6M Customer Records Across Japan Clinics
  • SBC Medical Confirms Breach of 1.62M Customer Records Across Japanese Clinics
  • SBC Medical Q3 10-Q: Revenue Up 35% to $59M, But Material Weaknesses Persist and Nasdaq Notice Stands
  • SBC Medical Q3 Revenue Jumps 35% as Operating Income Climbs 66%
  • Strong Q2 Earnings Can't Mask Nasdaq Non-Compliance and Persistent Control Weaknesses at SBC Medical

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$173.61M
Net Income
$50.99M
Diluted EPS
$0.50
Op. Cash Flow
$24.67M
Free Cash Flow
$23.27M
Gross Profit
$127.28M
Operating Income
$67.49M
Cash & Equivalents
$163.77M
Total Debt
$228.21K
Debt / Equity
0.00×
Net Margin
29.4%
Shares Outstanding
102.58M sh
Source: 10-K · filed 2026-04-30 · accession 0001493152-26-020748

Short Interest & Short Volume

4.57 days to cover

FINRA reported short interest of 840,714 shares in SBC as of the October 30, 2026 settlement, a 12.0% increase from the prior period — about 4.6 days to cover at its recent average daily volume. On November 20, 2026, 54.4% of SBC volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)840,714 shares as of October 30, 2026
Change vs prior period▲ 12.0%
Days to cover4.57 at avg daily volume of 184,147
Daily short volume (FINRA facilities)54.4% of 108,693 shares on November 20, 2026
5-day average short volume61.2%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with S →
$5.1 -1.35% today
52-week range · as of 2026-11-19 $2.78 – $7.39
Market cap
$531.72M
Volume
377.7K (1.2× avg)
3-mo avg 312.7K
Live data · 2026-11-21 13:28 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed SBC - Latest Insights

SBC
Nov 18, 2026, 11:39 PM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $6.31
Real-time Price: $5.10 info
Change: -$1.21 (-19%) info
Market Cap: $531.719M info
SBC
Nov 18, 2026, 9:53 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $6.00
Real-time Price: $5.10 info
Change: -$0.900 (-15%) info
Market Cap: $531.719M info
SBC
Nov 13, 2026, 7:00 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $5.80
Real-time Price: $5.10 info
Change: -$0.700 (-12%) info
Market Cap: $531.719M info
SBC
Nov 13, 2026, 6:30 AM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $5.71
Real-time Price: $5.10 info
Change: -$0.610 (-11%) info
Market Cap: $531.719M info
SBC
Aug 13, 2026, 7:00 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $3.29
Real-time Price: $5.10 info
Change: +$1.81 (+55%) info
Market Cap: $531.719M info
SBC
Aug 13, 2026, 6:50 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.29
Real-time Price: $5.10 info
Change: +$1.81 (+55%) info
Market Cap: $531.719M info
SBC
Aug 13, 2026, 6:41 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $3.29
Real-time Price: $5.10 info
Change: +$1.81 (+55%) info
Market Cap: $531.719M info
SBC
Jul 14, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $3.09
Real-time Price: $5.10 info
Change: +$2.01 (+65%) info
Market Cap: $531.719M info
SBC
May 28, 2026, 6:09 AM EDT
Filing Type: DEF 14A
Importance Score:
9
Price at Filing: $3.10
Real-time Price: $5.10 info
Change: +$2.00 (+65%) info
Market Cap: $531.719M info
SBC
May 20, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.23
Real-time Price: $5.10 info
Change: +$1.87 (+58%) info
Market Cap: $531.719M info
SBC
May 15, 2026, 5:26 PM EDT
Filing Type: PRE 14A
Importance Score:
9
Price at Filing: $2.97
Real-time Price: $5.10 info
Change: +$2.13 (+72%) info
Market Cap: $531.719M info
SBC
May 14, 2026, 7:00 AM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $3.30
Real-time Price: $5.10 info
Change: +$1.80 (+55%) info
Market Cap: $531.719M info
SBC
May 14, 2026, 6:50 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $3.30
Real-time Price: $5.10 info
Change: +$1.80 (+55%) info
Market Cap: $531.719M info
SBC
Apr 30, 2026, 5:21 PM EDT
Filing Type: 10-K/A
Importance Score:
9
Price at Filing: $3.30
Real-time Price: $5.10 info
Change: +$1.80 (+55%) info
Market Cap: $531.719M info
SBC
Apr 29, 2026, 9:38 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $3.30
Real-time Price: $5.10 info
Change: +$1.80 (+55%) info
Market Cap: $531.719M info
SBC
Apr 21, 2026, 9:07 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
9
Price at Filing: $3.65
Real-time Price: $5.10 info
Change: +$1.45 (+40%) info
Market Cap: $531.719M info
SBC
Apr 20, 2026, 4:27 PM EDT
Filing Type: 424B7
Importance Score:
9
Price at Filing: $3.60
Real-time Price: $5.10 info
Change: +$1.50 (+42%) info
Market Cap: $531.719M info
SBC
Mar 27, 2026, 7:31 AM EDT
Filing Type: 10-K
Importance Score:
8
Price at Filing: $3.81
Real-time Price: $5.10 info
Change: +$1.29 (+34%) info
Market Cap: $531.719M info
SBC
Mar 27, 2026, 6:50 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $3.81
Real-time Price: $5.10 info
Change: +$1.29 (+34%) info
Market Cap: $531.719M info
SBC
Mar 27, 2026, 6:40 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $3.80
Real-time Price: $5.10 info
Change: +$1.30 (+34%) info
Market Cap: $531.719M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets